SATRALIZUMAB

UNII:	YB18NF020M
Formula:
Preferred Substance Name:	SATRALIZUMAB

1535963-91-7
ENSPRYNG
HUMANISED ANTI-IL-6 RECEPTOR MONOCLONAL ANTIBODY
IMMUNOGLOBULIN G2, ANTI-(HUMAN INTERLEUKIN 6 RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL SA237 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL SA237 LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G2-KAPPA, ANTI-(HUMAN INTERLEUKIN-6 RECEPTOR SUBUNIT ALPHA (IL-6RA, MEMBRANE GLYCOPROTEIN 80, CD126 ANTIGEN)) HUMANIZED MONOCLONAL ANTIBODY: .GAMMA.2 HEAVY CHAIN (1-443) (HUMANIZED VH (HOMO SAPIENS IGHV4-59*01 (76%) (IGHD)-IGHJ4*01 (92%)) (9.7.12) (1-119)-HOMO SAPIENS IGHG2*01 (CH1 C14>S(133), R16>K(135), E20>G(139), S21>G(140) H C4>S(221) CH2 H37>Q(266) CH3 R15>Q(353), Q79>E(417), N94>A(432), G106>-(444), K107>-(445)) (120-443)) (222-214')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-214') (HUMANIZED V-KAPPA (HOMO SAPIENS IGKV1-33*01 (82%) IGKJ2*01 (83%) (6.3.9) (1'-107')-HOMO SAPIENS IGKC*01 (108'-214')) DIMER (225-225'':228-228'')-BISDISULFIDE
SA237
SA-237
SAPELIZUMAB
SATRALIZUMAB [INN]
SATRALIZUMAB [JAN]
SATRALIZUMAB [MI]
SATRALIZUMAB [USAN]
SATRALIZUMAB [WHO-DD]
SATRALIZUMAB MWGE [WHO-DD]
SATRALIZUMAB-MWGE

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

SATRALIZUMAB

Synonyms and Mappings

Resources